Article Text

Download PDFPDF

BS7 Neurohumoral responses in Takotsubo syndrome
  1. Hilal Khan1,
  2. Amelia Rudd2,
  3. David Gamble2,
  4. Alice Mezincescu2,
  5. Lesley Cheyne2,
  6. Graham Horgan2,
  7. Neeraj Dhaun3,
  8. David E Newby3,
  9. Dana K Dawson2
  1. 1University of Aberdeen, Aberdeen, ABE AB252ZN, UK
  2. 2University of Aberdeen
  3. 3University of Edinburgh


Background We investigate if renin-angiotensin and endothelin-1 response pathways follow the same pattern of recovery as left ventricular ejection fraction in patients with takotsubo syndrome.

Methods Ninety takotsubo syndrome patients [n=30 in each of ‘acute’,‘convalescent’ (3–5 months) and ‘recovered’ (> 1 year) groups] who were on minimal or no medication and were free of any significant cardiac/metabolic co-morbidities, and 30 healthy controls were studied. Serum concentrations of renin, angiotensin converting enzyme, angiotensin II, big endothelin-1, endothelin-1 were measured using commercially available ELISA, and BNP was measured using an immunoassay.

Results Left ventricular ejection fraction was 38 ± 1.6 % in acute, 63 ± 2.0 % in convalescent and 64 ± 2.6 % in recovered takotsubo syndrome patients. As shown in the Figure, serum renin concentrations are persistently elevated after a takotsubo episode (p=0.03 vs controls). Angiotensin converting enzyme levels are significantly depressed during the acute phase compared to convalescent (p=0.004), recovered takotsubo (p=0.02) or controls (p=0.03). Angiotensin II is increased in takotsubo patients (p<0.001 vs controls) remaining persistently elevated long-term in the recovered group (p=0.03 vs controls). B-type natriuretic peptide concentrations remain elevated after a takotsubo episode compared to controls (p=0.003). Big endothelin-1 levels are unchanged, but endothelin-1 is significantly lower after takotsubo syndrome compared to controls (p=0.03).

Conclusions Despite ‘normalisation’ of the left ventricular ejection fraction, there is long-term maladaptive activation of renin-angiotensin system in takotsubo syndrome patients. This suggests therapy aimed at modulating this pathway may be beneficial in the long-term.

  • Takotsubo
  • Cardiomyopathy
  • Neurohumoral

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.